The use of hydroxycarbamide in children with sickle cell anemia

The use of hydroxycarbamide in children with sickle cell anemia

Background: Although hydroxycarbamide (hydroxyurea [HU]) has been in use for decades in both adults and child populations with sickle cell disease (SCD), its reported use has remained low in Africa and Nigeria where the largest number of SCD patients reside. Availability, cost, and concerns about sa...

Full description

Bibliographic Details
Main Authors: Hafsat Rufai Ahmad, Jamilu Abdullahi Faruk, Adekunle Matthew Sobowale, Amos Solomon, Adebiyi Niyi Mustapha, Olufemi Gboye Ogunrinde
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2018-01-01
Series:Sahel Medical Journal
Subjects:
Africa
sickle cell anemia. hydroxycarbamide/hydroxyurea
sickle cell disease
Online Access:http://www.smjonline.org/article.asp?issn=1118-8561;year=2018;volume=21;issue=4;spage=189;epage=193;aulast=Ahmad

Similar Items

Similar Items